Amicogen, Inc. — Investor Relations & Filings
Amicogen, Inc. is an industrial biotechnology company specializing in the development and production of specialty enzymes and proteins. The company operates across three primary business areas: Enzyme and Biopharmaceuticals, Healthcare and Nutrition, and Bioprocess and CDMO (Contract Development and Manufacturing Organization) services. Leveraging its proprietary enzyme technology, Amicogen creates innovative solutions for the biopharmaceutical, food, and cosmetics industries. The healthcare division develops and manufactures functional food ingredients and nutritional products. The company also provides bioprocess solutions, including protein purification resins and comprehensive CDMO services to support the biopharmaceutical sector.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 분기보고서 (2026.03) | 2026-05-14 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-04 | Korean | |
| 주식등의대량보유상황보고서(일반) | 2026-05-04 | Korean | |
| [기재정정]사업보고서 (2024.12) | 2026-04-30 | Korean | |
| [기재정정]분기보고서 (2025.03) | 2026-04-30 | Korean | |
| [기재정정]반기보고서 (2025.06) | 2026-04-30 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 45879546 | 분기보고서 (2026.03) | 2026-05-14 | Korean | ||
| 40830949 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-04 | Korean | ||
| 40830871 | 주식등의대량보유상황보고서(일반) | 2026-05-04 | Korean | ||
| 39073552 | [기재정정]사업보고서 (2024.12) | 2026-04-30 | Korean | ||
| 39073409 | [기재정정]분기보고서 (2025.03) | 2026-04-30 | Korean | ||
| 39073184 | [기재정정]반기보고서 (2025.06) | 2026-04-30 | Korean | ||
| 39073033 | [기재정정]분기보고서 (2025.09) | 2026-04-30 | Korean | ||
| 39072792 | [기재정정]사업보고서 (2025.12) | 2026-04-30 | Korean | ||
| 39066980 | [기재정정]사업보고서 (2025.12) | 2026-04-30 | Korean | ||
| 37959259 | [기재정정]전환사채(해외전환사채포함)발행후만기전사채취득 (제5회차) | 2026-04-28 | Korean | ||
| 37939432 | [기재정정]전환사채(해외전환사채포함)발행후만기전사채취득 (제4회차) | 2026-04-28 | Korean | ||
| 37939311 | [기재정정]전환사채(해외전환사채포함)발행후만기전사채취득 (제5회차) | 2026-04-28 | Korean | ||
| 34568163 | 전환가액의조정 (제6회차) | 2026-04-15 | Korean | ||
| 33095696 | 정기주주총회결과 | 2026-03-31 | Korean | ||
| 33012316 | 사업보고서 (2025.12) | 2026-03-23 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Roopa Industries Ltd.
Manufactures bulk drugs, intermediates, and fine chemicals …
|
530991 | IN | Manufacturing |
|
Ropharma S.A.
Operates in pharmaceutical production, distribution, retail…
|
RPH | RO | Manufacturing |
|
RPbio Inc.
A CDMO specializing in soft capsule technology for pharmace…
|
314140 | KR | Manufacturing |
|
RPG Life Sciences Limited
Integrated pharmaceutical firm producing generic and brande…
|
RPGLIFE | IN | Manufacturing |
|
RTA LABORATUVARLARI BİYOLOJİK ÜRÜNLER İLAÇ VE MAKİNE SANAYİ TİCARET A.Ş.
Develops and produces IVD products for molecular biology an…
|
RTALB | TR | Manufacturing |
|
Rua Bioscience Limited
Develops and manufactures pharmaceutical-grade medicinal ca…
|
RUA | NZ | Manufacturing |
|
RUBICON RESEARCH LIMITED
Develops complex drug delivery platforms and value-added ph…
|
RUBICON | IN | Manufacturing |
|
S2Medical AB
Develops solutions for wound healing and infection control …
|
S2M | SE | Manufacturing |
|
SAB Biotherapeutics, Inc.
Develops human polyclonal antibodies from transgenic cattle…
|
SABS | US | Manufacturing |
|
Sagimet Biosciences Inc.
Clinical-stage biopharma developing FASN inhibitors for met…
|
SGMT | US | Manufacturing |
Amicogen, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/16981/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=16981 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=16981 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=16981 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 16981}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Amicogen, Inc. (id: 16981)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.